| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (67件)
- Hiroki Yanagisawa, Hitoshi Maeda, Isamu Noguchi, Motohiko Tanaka, Naoki Wada, Taisei Nagasaki, Kazuki Kobayashi, Gai Kanazawa, Kazuaki Taguchi, Victor Tuan Giam Chuang, et al. Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation. Redox Biology. 2024. 76. 103314-103314
- Kai Tokumaru, Tadashi Imafuku, Takao Satoh, Tomoaki Inazumi, Shu Hirashima, Ayano Nishinoiri, Taisei Nagasaki, Hitoshi Maeda, Yukihiko Sugimoto, Motoko Tanaka, et al. Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis: Identification of Antifibrotic Metabolites. Kidney360. 2024
- Yuka Nakamura, Hiroshi Watanabe, Teruya Nakamura, Mami Chirifu, Kana Ishiodori, Tadashi Imafuku, Hitoshi Maeda, Yoshihiro Kobashigawa, Hiroshi Morioka, Toru Maruyama. Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α1-Acid Glycoprotein. Molecular Pharmaceutics. 2024
- Yuka Nakamura, Hiroshi Watanabe, Tadashi Imafuku, Issei Fujita, Yuto Ganaha, Toru Takeo, Naomi Nakagata, Hitoshi Maeda, Toru Maruyama. Contribution of the α1-Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α1-Acid Glycoprotein-Knockout Mice. Molecular Pharmaceutics. 2024
- Naoya Iwamoto, Takuma Kai, Shinsuke Inuki, Hiroaki Ohno, Hitoshi Maeda, Hiroshi Watanabe, Toru Maruyama, Shinya Oishi. Mirror-Image Human Serum Albumin Domain III as a Tool for Analyzing Site II-Dependent Molecular Recognition. Bioconjugate Chemistry. 2024
- Kazuaki Taguchi, Shigeru Ogaki, Hitoshi Maeda, Yu Ishima, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama. Carbon Monoxide Alleviates Post-ischemia-reperfusion Skeletal Muscle Injury and Systemic Inflammation. Biological and Pharmaceutical Bulletin. 2024. 47. 4. 868-871
- Isamu Noguchi, Hitoshi Maeda, Kazuki Kobayashi, Taisei Nagasaki, Hiromasa Kato, Hiroki Yanagisawa, Naoki Wada, Gai Kanazawa, Tsubasa Kaji, Hiromi Sakai, et al. Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment. Free Radical Biology and Medicine. 2024
- Kentaro Oniki, Masatsune Ogura, Erika Matsumoto, Hiroshi Watanabe, Tadashi Imafuku, Yuri Seguchi, Yuichiro Arima, Koichiro Fujisue, Kenshi Yamanaga, Eiichiro Yamamoto, et al. Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction. Journal of atherosclerosis and thrombosis. 2024
- Yuki Minayoshi, Hitoshi Maeda, Keisuke Hamasaki, Taisei Nagasaki, Mei Takano, Ryo Fukuda, Yuki Mizuta, Motohiko Tanaka, Yutaka Sasaki, Masaki Otagiri, et al. Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals. 2024. 17. 2. 260-260
- 前田 仁志, 猿渡 淳二, 古郡 規雄. 【精神疾患における環境要因と遺伝-環境相互作用】精神科領域の薬物相互作用 統合失調症患者における喫煙の影響を含めた薬物動態学的相互作用. 医学のあゆみ. 2024. 288. 7. 583-589
- Ryota Murata, Hiroshi Watanabe, Ryotaro Iwakiri, Mayuko Chikamatsu, Takao Satoh, Isamu Noguchi, Kengo Yasuda, Ayano Nishinoiri, Takuma Yoshitake, Hiroto Nosaki, et al. Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis. Heliyon. 2024. 10. 3. e25485-e25485
- Hitoshi Maeda. Albumin-based Drug Delivery System Targeting Mannose Receptors and Its Application to Medical Treatments. YAKUGAKU ZASSHI. 2023. 143. 11. 923-930
- Mei Takano, Hiroshi Watanabe, Shota Toda, Kento Nishida, Tadashi Imafuku, Yuki Minayoshi, Takehiro Nakano, Hitoshi Maeda, Toru Maruyama. Therapeutic Effects of Albumin-Fused BMP7 on 2 Experimental Models of Liver Fibrosis. Biological and Pharmaceutical Bulletin. 2023. 46. 10. 1421-1426
- Taisei Nagasaki, Hitoshi Maeda, Hiroki Yanagisawa, Kento Nishida, Kazuki Kobayashi, Naoki Wada, Isamu Noguchi, Ryotaro Iwakiri, Kazuaki Taguchi, Hiromi Sakai, et al. Carbon Monoxide-Loaded Red Blood Cell Prevents the Onset of Cisplatin-Induced Acute Kidney Injury. Antioxidants. 2023. 12. 9. 1705-1705
- 徳丸 碧海, 渡邊 博志, 今福 匡司, 佐藤 崇雄, 稲住 知明, 前田 仁志, 杉本 幸彦, 丸山 徹. ω3系脂肪酸によるAKI to CKD抑制効果と脂肪酸活性代謝物の同定. 脂質生化学研究. 2023. 65. 147-148
- Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Kohichi Yamada, et al. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease. Journal of controlled release : official journal of the Controlled Release Society. 2023. 355. 42-53
- Nanaka Arimura, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda, et al. Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins. 2023. 15. 3. 179-179
- Yasuda Kengo, Maeda Hitoshi, Kinoshita Ryo, Minayoshi Yuki, Mizuta Yuki, Nakamura Yuka, Imoto Shuhei, Nishi Koji, Yamasaki Keishi, Sakuragi Mina, et al. Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticle for the Treatment of Hepatitis. ACS Nano. 2023
- Hitoshi Maeda, Shota Ichimizu, Hiroshi Watanabe, Keisuke Hamasaki, Mayuko Chikamatsu, Ryota Murata, Nao Yumoto, Takahiro Seki, Hiroshi Katsuki, Masaki Otagiri, et al. Cell-penetrating albumin enhances the sublingual delivery of antigens through macropinocytosis. International journal of biological macromolecules. 2022. 221. 1439-1452
- Mei Takano, Shota Toda, Hiroshi Watanabe, Rui Fujimura, Kento Nishida, Jing Bi, Yuki Minayoshi, Masako Miyahisa, Hitoshi Maeda, Toru Maruyama. Engineering of a Long-Acting Bone Morphogenetic Protein-7 by Fusion with Albumin for the Treatment of Renal Injury. Pharmaceutics. 2022. 14. 7
前のページに戻る
